Viewing Study NCT06319521



Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06319521
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-20
First Post: 2024-03-10

Brief Title: Stellate Ganglion Block on Gastroesophageal Reflux Disease
Sponsor: Copka Sonpashan
Organization: Chao Phya Abhaibhubejhr Hospital

Study Overview

Official Title: A Randomized Controlled Study to Explore Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to explore Clinical Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease The main question it aims to answer is

Can stellate ganglion block improve gastroesophageal reflux symptoms better on the basis of rehabilitation training Participants will be randomly allocated into the control group or the experimental group all under rehabilitation treatment the experimental group will be given Stellate Ganglion Block once a day additionally The study lasts 20 days for each participant Researchers will compare the Gastroesophageal Reflux Disease Questionnaire Pressure pain threshold Self-Evaluation Questionnaire for Gastroesophageal Reflux Disease to see if the Stellate Ganglion Block can help improve the symptom
Detailed Description: Gastroesophageal reflux is a common digestive disorder characterized by the backflow of stomach contents and fluids into the esophagus

The goal of this clinical trial is to explore Clinical Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease The main question it aims to answer is

Can stellate ganglion block improve gastroesophageal reflux symptoms better on the basis of rehabilitation training Participants will be randomly allocated into the control group or the experimental group all under rehabilitation treatment the experimental group will be given Stellate Ganglion Block once a day additionally The study lasts 20 days for each participant Researchers will compare the Gastroesophageal Reflux Disease Questionnaire Pressure pain threshold Self-Evaluation Questionnaire for Gastroesophageal Reflux Disease to see if the Stellate Ganglion Block can help improve the symptom

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None